Peer Review History
| Original SubmissionSeptember 28, 2025 |
|---|
|
Dear Dr. Marshall, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Based on the review reports, authors should consider the following points before revision submission. Specificity of terminology is strongly suggested for clarity in different sections of the manuscript. Develop a strong background leading to stepwise methodology and especially the critical discussion to strengthen your findings with the previous findings. conclusion should be to the point and based on the findings of the study. Please submit your revised manuscript by Dec 06 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Munir Ahmad, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. 3. Thank you for stating the following financial disclosure: [K.E.M. NSERC Discovery K.v.d.B. NSF DBI-2208932 A.D.R. Genomics Research and Development Initiative (GRDI-Government of Canada)]. Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 4. Thank you for stating the following in the Acknowledgments Section of your manuscript: [KEM is supported by an NSERC Discovery Grant. KB is supported by the NSF award DBI-2208932. Support was provided to ADR by funding from the Genomics Research and Development Initiative (GRDI-Government of Canada).] We note that you have provided funding information that is currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: [K.E.M. NSERC Discovery K.v.d.B. NSF DBI-2208932 A.D.R. Genomics Research and Development Initiative (GRDI-Government of Canada)] Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 5. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process. 6. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. 7. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 8. Please upload a copy of Supporting Information Tables S1, S2, S3, S4, and S5 which you refer to in your text on pages 8, 10, and 11. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Additional Editor Comments: Based on the review reports, authors should consider the following points before revision submission. Specificity of terminology is strongly suggested for clarity in different sections of the manuscript. Develop a strong background leading to stepwise methodology and especially the critical discussion to strengthen your findings with the previous findings. conclusion should be to the point and based on the findings of the study. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Partly Reviewer #2: Yes Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: No Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** Reviewer #1: I believe there are a few questions and points must be addressed prior to publication. 1) The introduction would benefit from more background on insect diapause. 2) The material and methods section did not clearly describe how the non-diapause strains were obtained, what percentage of the non-diapause larvae were induced, and what the variations between generations were. These points are essential in being able to compare the gene expression between the non-diapause and diapause strains. 3) Does someone's lab maintain these non-diapausing strains? 4) Discussion section should link current research to previous research. 5) There is not enough data to support the conclusion that the signal that induces diapause occurs early in the first instar. Reviewer #2: This is an interesting paper that utilizes a unique comparison of spruce budworm individuals from lines that are either diapause capable or diapause incapable to identify genetic architecture of diapause and gene expression leading up to diapause. This provides a comparison that contrasts with most published work on diapause gene expression that looks at variation across natural gradients. The authors found that there are no clear major genetic rearrangements responsible for the differences and there are differences observed in gene expression leading up to diapause. It is a novel study and a well written paper. I enjoyed reading it, but I do have some comments regarding the interpretation of results and the terminology used. The major comments are: 1) First, I think that the names of the strains are a bit misleading. Diapause is a developmental process, and what is being compared is the genomes and gene expression of individuals in development mostly before they are in diapause. This can lead to potentially misusing the names of the strains with the process, like on L368, when it is said that “...upregulation of genes in diapausing spruce budworm...”, where the expression was not measured in individuals in diapause. This is mostly avoided by referring to them as diapause strain though. I would recommend making this more clear by calling the strains diapause capable or diapause incapable, or something like that. 2) I am also struggling a bit to wrap my head around what question the experimental design is addressing. Generally, the expression papers that are cited as comparisons here are looking at natural variation in diapause cues that adapt to local environment. I would consider diapause inducing cues to be different from diapause or diapause regulation, they are linked, but not the same. Populations that have differing critical photoperiods would differ when they enter, but once they are in diapause the diapause is likely very similar. So then what is being compared between your strains? It is a little complicated by them being obligate, but still able to respond to extreme photoperiod (L395). Do the individuals selected in the non-diapause strain lack the ability to trigger the induction phase, or is it something else in the cascade leading to diapause? If you are looking at more complicated trait, then it could explain why in L301 says your findings are in contrast to other studies which have loci of large effect when they are looking at photoperiod or other cues. 3) I also wonder about the function of individuals in a population that do not enter diapause. I would expect they would have very low fitness as they likely have low survival. Would it be some form of bet hedging? There is often strong selection on critical photoperiod because it is important for survival to enter diapause at the right time, and since there are loci of large effect underlying these traits usually, selection acts on it quickly. This also may explain why you do not find strong evidence of loci of large effect. I do not mean for this comment and the last to sound critical, I find it to be a very interesting part of the system and study, and perhaps would have liked a little bit more of it in the discussion. 4) I find Figures 4-6 to undermine the methods a bit. I am not questioning the validity of the methods used, but the data shown in these figures rely on having a different expression profile, and in every case, they seem to be very similar expression profiles when shown in panels B and C. I was thinking that maybe making a supplementary figure of an example of several of the discussed transcripts in non-diapause and diapausing strains to show their divergent expression. The differences may look more convincing when not grouped with hundreds of others. This may give the readers some reassurance that they differ. This is just a suggestion though, and I think it is ok without it. Minor comments: L28: Would this be “...a small subset of individuals do not diapause...”? L72: I see that here you mention that you are looking at diapause induction and not diapause in general, maybe this needs to be clarified throughout. L355: There is no panel F in Figure 4, L395: I think that it would be useful to add that they also can be induced to skip diapause when exposed to long photoperiod in the introduction. Reviewer #3: This well written manuscript explores the differences between diapausing and non-diapausing spruce budworm in the genome as well as in the transcriptome. This approach to study multiple genetic traits behind the change from obligate to facultative and in the end no diapause within a one population is appealing. Here the authors present a study in which they were able to show that the change in life history decision comes mainly from the transcriptome and not genetic variation. The time points for the gene expression were smartly chosen to get as close to this decision as possible. Overall, I think this is a well-designed experiment with good execution and written up in a concise manuscript. Therefore, as a reviewer I would suggest this manuscript for publication, after the minor comments have been addressed by the authors. Line 62 & 71: Responsive diapause is more commonly termed facultative diapause and it might be better to talk about facultative diapause that is responsive instead of responsive diapause. Line 91 – 116: Please go through the text and put all the species names in italic. Line 168: If you follow kostal 2006 diapause is first induced and then initiated and as I understand diapause is induced in the first instar and initiated in the early second instar in your species. Could you change from induced to initiated. Did you sample the eggs and instars always at the same time after lights on, as you were looking for changes in circadian clock genes? Figure 1 or methods: could you describe the timeframe for the insects how long the egg, L1 and L2 stage last. That would make it easier to assess the scope of the transcriptomic changes. ********** what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No Reviewer #3: Yes: Philip Süess ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 1 |
|
Major changes in gene expression between strains of diapausing and non-diapause spruce budworm PONE-D-25-52868R1 Dear Dr. Marshall, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Michael Schubert Academic Editor PLOS One Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #2: All comments have been addressed Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #2: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #2: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #2: Yes Reviewer #3: Yes ********** Reviewer #2: I appreciate the authors efforts in addressing my previous comments, and I believe that they have sufficiently addressed them. I believe the manuscript in its current form is ready for publication, and I look forward to citing this paper in the future. Reviewer #3: The comments and questions I had concerning the manuscript have been addressed and the added text and revised nomenclature satisfies my requests. ********** what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #2: No Reviewer #3: No ********** |
| Formally Accepted |
|
PONE-D-25-52868R1 PLOS One Dear Dr. Marshall, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Michael Schubert Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .